Kamunting Street Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kamunting Street Capital Management's BMY Position: Q4 2021 in Review
Kamunting Street Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 25,000 shares — an estimated $1.48M sold.
Kamunting Street Capital Management first reported a position in BMY in Q1 2019 and held it in 4 quarters. The position peaked at $5.01M in Q2 2019. 2,446 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Kamunting Street Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- Kamunting Street Capital Management sold 25,000 Bristol-Myers Squibb shares in Q4 2021, an estimated $1.48M.
- Kamunting Street Capital Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 4 quarters.
- Kamunting Street Capital Management's Bristol-Myers Squibb position peaked at $5.01M in Q2 2019.
- 2,446 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Kamunting Street Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.